Product Information

LOJAIMIESS 0.1-0.02-0.01 TAB is a generic product labeled by Xiromed LLC, priced at $0.2331 per EA under NDC 70700012487. Its NADAC has been published 348 times since Mar 18, 2020.

FDA first approved this application on Dec 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOJAIMIESS 0.1-0.02-0.01 TAB

levonorgestrel/ethinyl estradiol and ethinyl estradiol
$0.2331per EA

Manufacturer

Xiromed LLC

NDC

70700012487

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205131

FDA Approved

12/14/2017

TE Code

AB

On Market Since

2/11/2019

Price Statistics

The NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has been published 348 times since Mar 18, 2020, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2331 per EA
All-time high$0.4996 (Aug 12, 2020)
All-time low$0.1337 (Jul 17, 2024)
52-week high$0.2436
52-week low$0.1911
Median price$0.2649
Average price$0.2748
Largest weekly change+86.4% (Nov 22, 2023)
Weeks tracked348
Tracking sinceMar 18, 2020

Price History

1W

0.0%

1M

-0.3%

3M

-1.7%

6M

-3.1%

1Y

+12.4%

3Y

+47.4%

5Y

-14.1%

All

-36.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levonorgestrel/ethinyl estradiol and ethinyl estradiol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOJAIMIESS 0.1-0.02-0.01 TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOJAIMIESS 0.1-0.02-0.01 TAB, manufactured by Xiromed LLC, is $0.2331 per EA (NDC 70700012487), effective Nov 11, 2026.

How has the price of LOJAIMIESS 0.1-0.02-0.01 TAB changed over time?

Over the history we have for it, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has declined 36.9%. It has been tracked across 348 weekly CMS publications since Mar 18, 2020.

What are the highest and lowest recorded NADAC prices for LOJAIMIESS 0.1-0.02-0.01 TAB?

Since Mar 18, 2020, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $0.4996 (Aug 12, 2020), with a median of $0.2649 per EA.

Are there cheaper alternatives to LOJAIMIESS 0.1-0.02-0.01 TAB?

No other NADAC-published product currently shares the active ingredient and strength of LOJAIMIESS 0.1-0.02-0.01 TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LOJAIMIESS 0.1-0.02-0.01 TAB?

LOJAIMIESS 0.1-0.02-0.01 TAB (NDC 70700012487) is labeled by Xiromed LLC, and CMS classifies it as a generic product.